Therapeutic applications of immunomagnetic cell selection: A review

European Cells and Materials

Volumn 3, Issue SUPPL. 2, 2002, Pages 37-40

  Farag, S S ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2442656990     PISSN: 14732262     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Gribben JG, et al. 1991. Immunological purging of marrow assessed by PCR before autologous bone marrow transplantation for B cell lymphoma. N Engl J Med 325: 1525-33.
2. Feedman A, et al. 1997. Long term prolongation of disease free survival and overall survival following autologous bone marrow transplantation in patients with advanced relapsed follicular lymphoma. Proc Am Soc Clin Oncol 89 (abstract 304).
3. Di Nicola M, et al. 1996. Combined negative and positive selection of mobilized CD34 blood cells. Br J Hematol 94: 716-21.
4. Lopez M, et al. 1997. Bone marrow versus peripheral blood progenitor cell CD34 selection in patients with non-Hodgkin's lymphomas: different levels of tumor cell reduction. Imnplications for autografting. Blood 90: 2830-38.
5. Lemoli RM, et al. 1999. Selection and transplantation of autologous CD34+ Blineage negative cells in advanced-phase multiple myeloma patients: a pilot study. Br J Hematol 107: 419-28.
6. Abnour R, et al. 1998. Autologous transplantation of mobilized peripheral blood CD34+ cells selected by immunomagnetic procedures in patients with multiple myeloma. Bone Marrow Transplant 22: 957-63.
7. Cancelas JA, et al. 1999. peripheral blood CD34+ cell immunomagnetic selection in breast cancer patients: effect on hematopoietic progenitor content and hematologic recovery after high-dose chemotherapy and autotransplantation. Transfusion 38: 1063-70.
8. Yanovich S, et al. 2000. Transplantation of CD34+ peripheral blood cels selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized clinical trial. Bone Marrow Transplant 25: 1165-74.
9. Przepiorka D. Prevention of acute graft versus host disease. 2000. In Ball ED, Lister J, Law P (Eds). Hematopoietic Stem cell therapy. Churchill Livingston, NY, pp 452-69.
10. Reisner Y, Martelli MF. 2000. Tolerance induction by 'megadose' transplants of CD34+ stem cells: a new option for leukemia patients without an HLA-matched donor. Current Opinion in Immunol 12: 536.
11. Aversa F. et al. 1998. Treatment of high-risk acute leukemia with T-cell depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 339: 1186.
12. Ruggeri L, Capanni M, Aristei C, et al. 2000. Mini mismatched transplantation in the mouse by the use of alloreactive NK cells for conditioning. Blood 96: 473a.
13. Handgretinger R, et al. 1997. Positive selection and transplantation of peripheral CD34+ progenitor cells: feasibility and purging efficacy in pediatric patients with neuroblastoma. J Hematother 6: 235-42.
14. Hassan HT, Zeller W, Stockschlader M, et al. 1997. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection. Stem Cells 14: 419-29.
15. Johnson RJ, et al. 1996. Peripheral blood stem cell transplantation in myeloma using CD34 selected cells. Bone Marrow Transplant. 17: 723-7.
16. Lane TA, et al. 1995. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colonystimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation. Blood 85: 275-82.
17. Civin CI, et al. 1996. Highly purified CD34-positive cells reconstitute hematopoiesis. J Clin Oncol. 14: 2224-33.
18. Mapara MY, et al. 1997. Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparison of immunocytochemical tumor cell staining and reverse transcriptasepolymerase chain reaction. Blood 89: 337-44.
19. Martin-Henao GA, et al. 2000. Isolation of CD34+ progenitor cells from peripheral blood by use of an automated immunomagnetic selection system: factors affecting the results. Transfusion 40: 35-43.
20. Martin-Henao GA, et al. 2001. Combined positive and negative cell selection from allogeneic peripheral blood progenitor cell (PBPC) by use of immunomagnetic methods. Bone Marrow Transplant 27: 683-87.
21. McNiece I, et al. 1997. Large-scale isolation of CD34+ cells using the Amgen cell selection device results in high levels of purity and recovery. J Hematother 6: 5-11.
22. Schumm M, et al. 1999. Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device. J Hematother 8: 209-18.
23. Korbling M. 1999. Collection of allogeneic peripheral blood stem cells. Balliere's Clinical Haematology 12: 41-45.
24. Frohn C, et al. Feasibility of the adoptive transfusion of allogeneic human leukocyte antigen-matched natural killer cells in patients with renal cell carcinoma. J Immunother 23: 499-504.
25. Koehl U, Barting T, Esser R, et al. 2000. Large scale isolation of natural killer cells from haploidentical donors for posttransplant immunotherapy. Bone Marrow Transplant 25 (Suppl 1): S123.